Reports

Ideas That Generate Results

Global Influenza Vaccine Market Outlook 2022

Global Influenza Vaccine Market Outlook 2022

Format :  Adobe Reader (PDF) Upto 24 hour delivery
Publish Date : Jun, 2016| No. of Pages : 95

Share |
 
Please make your selection :
Electronic Access - Single User License
US$ 2100.00
CD-ROM Mail Delivery
US$ 2200.00
Hard Copy Mail Delivery
US$ 2200.00
Electronic Access - Multi-User License
US$ 3000.00

List of Figures:

Figure 6-1: Global - Influenza Vaccine Sales (Million Doses), 2015 & 2022
Figure 6-2: Global - Influenza Vaccine Market (Billion US$), 2015-2022
Figure 6-3: Global - Influenza Vaccine Market by Players (%), 2015
Figure 6-4: Global - Fluzone/Vaxigrip Sales (Million US$), 2011-2015
Figure 6-5: Global - FluMist Sales (Million US$), 2011-2015
Figure 6-6: Global - Fluarix and FluLaval Sales (Million US$), 2011-2015
Figure 6-7: Global - Anflu Sales (Million Doses), 2011-2015
Figure 6-8: Global - Anflu Sales (Million US$), 2011-2015
Figure 6-9: Global - Afluria/Fluvax Sales (Million US$), 2013-2015
Figure 6-10: Global - Flucevax and Fluvirin Sales (Million US$), 2013-2015
Figure 7-1: Global - Influenza Vaccine Market by Region (%), 2015
Figure 7-2: US - Influenza Vaccine Sales (Million Doses), 2011-12 to 2015-16
Figure 7-3: Americas - Influenza Vaccine Market by Players (%), 2015
Figure 7-4: Americas - Influenza Vaccine Market (Billion US$), 2015-2022
Figure 7-5: Europe - Influenza Vaccine Market by Players (%), 2015
Figure 7-6: Europe - Influenza Vaccine Market (Billion US$), 2015-2022
Figure 7-7: Europe - Seasonal Influenza Vaccination Coverage in Older Age Group by Country (%), 2011-12 & 2012-13
Figure 7-8: Asia-Pacific - Influenza Vaccine Market by Players (%), 2015
Figure 7-9: Asia Pacific - Influenza Vaccine Market (Billion US$), 2015-2022
Figure 7-10: Rest of the World - Influenza Vaccine Market (Billion US$), 2015-2022
Figure 8-1: Global - Breakup of Influenza Vaccine Pipeline by Type of Vaccine
Figure 10-1: Sanofi - Breakup of Total Revenues by Business Segment (%), 2015
Figure 10-2: Sanofi Pasteur - Breakup of Vaccine Segment by Type (%), 2015
Figure 10-3: Sanofi Pasteur - Breakup of Total Influenza Vaccine Revenues by Geography (%), 2015
Figure 10-4: GlaxoSmithKline Plc - Breakup of Total Revenues by Business Segment (%), 2015
Figure 10-5: GlaxoSmithKline Plc - Breakup of Vaccine Segment by Type (%), 2015
Figure 10-6: GlaxoSmithKline Plc - Breakup of Total Influenza Vaccine Revenue by Geography (%), 2015
Figure 10-7: CSL Ltd - Breakup of Total Revenues by Business Segment (%), 2015
Figure 10-8: CSL Ltd - Breakup of bioCSL Revenues by Product Type (%), 2015
Figure 10-9: AstraZeneca Plc - Breakup of Total Revenues by Business Segment (%), 2015
Figure 10-10: AstraZeneca Plc - Breakup of Infection Segment by Type (%), 2015
Figure 10-11: AstraZeneca Plc - Breakup of Total Influenza Vaccine Revenues by Geography (%), 2015
Figure 10-12: Sinovac Biotech - Breakup of Vaccine Revenue by Type (%), 2015
 
List of Tables:

Table 7-1: US - Major Influenza Vaccines & Manufacturers (2015-16)
Table 7-2: US - Percentage of Children Who Received Influenza Vaccine (2015-16)
Table 7-3: US - Percentage of Adults Who Received Influenza Vaccine (2015-16)
Table 7-4: US - Number of Pediatric Deaths in Flu Season (2005-06 to 2015-16)
Table 7-5: Europe - Major Influenza Vaccines & Manufacturers (2015-16)
Table 7-6: China - Vaccine Classification
Table 7-7: Australia - Major Influenza Vaccines & Manufacturer (2016)
Table 8-1: Global - Influenza Vaccine Pipeline Analysis
Table 9-1: Global - Major Influenza Vaccines Cost/Dose (US$), 2016-17
Table 10-1: Sanofi - Key Financials (Million US$), 2013-2015
Table 10-2: Sanofi - Influenza Vaccines Offered
Table 10-3: GlaxoSmithKline Plc - Key Financials (Million US$), 2013-2015
Table 10-4: GlaxoSmithKline Plc - Influenza Vaccines Offered
Table 10-5: CSL Ltd. - Key Financials (Million US$), 2013-2015
Table 10-6: CSL - Influenza Vaccine Portfolio before Merger
Table 10-7: CSL - Influenza Vaccine Portfolio after Merger
Table 10-8: AstraZeneca Plc - Key Financials (Million US$), 2013-2015
Table 10-9: AstraZeneca Plc - Influenza Vaccines Offered
Table 10-10: Sinovac Biotech - Key Financials (Million US$), 2013-2015
Table 10-11: Sinovac Biotech - Influenza Vaccines Offered

Not able to find data you are looking for? Ask our Research Analyst.

media citation

get in touch

Please fill-in the information below.